Rankings
▼
Calendar
AMRN Q2 2025 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena
AMRN
Amarin Corporation plc
$310M
Q2 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$73M
+7.7% YoY
Gross Profit
$50M
69.2% margin
Operating Income
-$16M
-22.0% margin
Net Income
-$14M
-19.4% margin
EPS (Diluted)
$-0.68
QoQ Revenue Growth
+73.1%
Cash Flow
Operating Cash Flow
$17M
Free Cash Flow
$17M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$670M
Total Liabilities
$205M
Stockholders' Equity
$465M
Cash & Equivalents
$148M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$73M
$68M
+7.7%
Gross Profit
$50M
$42M
+19.8%
Operating Income
-$16M
-$524,587
-2947.2%
Net Income
-$14M
$2M
-1027.9%
Revenue Segments
Product
$47M
64%
Licensing And Royalty
$26M
36%
Geographic Segments
UNITED STATES
$37M
85%
Europe
$7M
15%
← FY 2025
All Quarters
Q3 2025 →